Home » Authors » Mark McCarty

Articles by Mark McCarty

Washington roundup: Fetal oximetry data falls short, Nellcor terminates production

Nov. 30, 2006

By Mark McCarty

Fetal oximetry data falls short, Nellcor terminates production

Nov. 28, 2006

By Mark McCarty

Washington roundup: Study: Medicaid limits stunt migration to managed care

Nov. 27, 2006

By Mark McCarty

SPORT trial hints wait-and-treat may be as effective as surgery

Nov. 27, 2006

By Mark McCarty

Speakers argue vs. Medicare pay for hospital infections

Nov. 22, 2006

By Mark McCarty

IOM report drives senate look at FDA post-market surveillance

Nov. 20, 2006

By Mark McCarty

FDA s Gottlieb floats user fee balloon to cover surveillance

Nov. 16, 2006

By Mark McCarty

Consumers are catching on to healthcare dilemmas facing U.S.

Nov. 15, 2006

By Mark McCarty

Those with equity like devices, but regs make investors wary

Nov. 13, 2006

By Mark McCarty

Reimbursement hurdles seen as benefit as well as barrier

Nov. 10, 2006

By Mark McCarty

Popular Stories

Bio Korea 2026 kicks off with spotlight on oligonucleotides
BioWorld
Three decades of trial-and-error, and the resulting safety data, in the oligonucleotide-based therapeutic space have paved way for the present-day innovations and...
Chinese biotechs gain leverage as partners in dealmaking
BioWorld
China’s biotech ecosystem has crossed an inflection point, and Chinese biotechs are gaining leverage in dealmaking, executives from multinational companies said...
University of Western Australia patents 5-HT2A/B modulators
BioWorld Science
University of Western Australia has identified new lysergic acid diethylamide (LSD) analogues acting as 5-HT2A and 5-HT2B modulators reported to be useful for the...
AA meeting of minds as PTC, Novartis push votoplam in HD
BioWorld
What PTC Therapeutics Inc.’s latest data with votoplam might mean in the Huntington’s disease (HD) landscape became grist for Wall Street after the firm unveiled...
Innervation can slow, as well as speed, tumor growth, study finds
BioWorld
Innervation by the sympathetic nervous system is typically a boon to tumors. But researchers from Weill Cornell Medicine and colleagues have shown that in some...